Insider Trading & Ownership - Enliven Therapeutics Inc. (ELVN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Enliven Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-25
Sale
2024-03-27
5:03 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,000$17.56$210,6611,525,137
(Indirect
Direct)
View
2024-03-20
Sale
2024-03-22
7:46 pm
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
13,278$19.16$254,46241,912
(Direct)
View
2024-03-19
Sale
2024-03-21
6:41 pm
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
1,270$14.5$18,419210,093
(Indirect
Direct)
View
2024-03-06
Sale
2024-03-08
7:52 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
4,875$15.64$76,239401,499
(Indirect
Direct)
View
2024-02-29
Sale
2024-03-04
5:55 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,000$16.42$197,0061,389,585
(Indirect
Direct)
View
2024-02-27
Sale
2024-02-29
5:27 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$16.97$55,163242,620
(Direct)
View
2024-02-26
Sale
2024-02-28
5:14 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,000$16.89$202,6531,537,137
(Indirect
Direct)
View
2024-02-15
Sale
2024-02-20
7:41 pm
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
1,270$17.42$22,117211,363
(Indirect
Direct)
View
2024-02-14
Sale
2024-02-16
4:15 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
825,000$14.9$12,292,500635,341
(Indirect)
View
2024-02-06
Sale
2024-02-08
8:47 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
4,875$15.11$73,658406,374
(Indirect
Direct)
View
2024-01-31
Sale
2024-02-02
4:29 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
500,000$15$7,500,000771,983
(Indirect)
View
2024-01-30
Sale
2024-02-01
8:10 pm
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
1,270$16.41$20,840212,633
(Indirect
Direct)
View
2024-01-29
Sale
2024-01-31
9:22 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,000$15.85$190,2561,401,585
(Indirect
Direct)
View
2024-01-29
Sale
2024-01-31
9:20 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$15.81$51,388245,870
(Direct)
View
2024-01-25
Sale
2024-01-29
8:01 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
12,000$15.69$188,2291,549,137
(Indirect
Direct)
View
2024-01-22
Sale
2024-01-24
6:38 pm
Enliven Therapeutics Inc.ELVNPatel Anish
Chief Operating Officer
4,875$15.13$73,783411,249
(Indirect
Direct)
View
2023-12-29
Sale
2024-01-03
7:01 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
12,000$14.28$171,3811,413,585
(Indirect
Direct)
View
2023-12-28
Sale
2024-01-02
8:00 pm
Enliven Therapeutics Inc.ELVNPatel Anish
Chief Operating Officer
13,540$15.02$203,348416,124
(Indirect
Direct)
View
2023-12-28
Sale
2024-01-02
7:59 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
11,870$15.02$178,327766,146
(Direct)
View
2023-12-26
Sale
2023-12-28
4:29 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
12,000$14.64$175,7091,561,137
(Indirect
Direct)
View
2023-12-22
Sale
2023-12-27
5:28 pm
Enliven Therapeutics Inc.ELVNPatel Anish
Chief Operating Officer
1,085$15.03$16,306429,664
(Indirect
Direct)
View
2023-12-22
Sale
2023-12-27
5:26 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
1,130$15.07$17,025522,080
(Direct)
View
2023-12-21
Sale
2023-12-26
7:32 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
6,566$13.07$85,7901,740,681
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-25
Exercise
2024-03-27
5:03 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,000$1.121,525,137
(Direct)
View
2024-03-25
Exercise
2024-03-27
5:03 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,000$01,525,137
(Direct)
View
2024-03-20
Exercise
2024-03-22
7:46 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
13,278$5.5241,912
(Direct)
View
2024-03-20
Exercise
2024-03-22
7:46 pm
N/A
2032-01-27
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
13,278$041,912
(Direct)
View
2024-02-29
Exercise
2024-03-04
5:55 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,000$1.121,389,585
(Direct)
View
2024-02-29
Exercise
2024-03-04
5:55 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,000$01,389,585
(Direct)
View
2024-02-27
Exercise
2024-02-29
5:27 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0242,620
(Direct)
View
2024-02-27
Exercise
2024-02-29
5:27 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48242,620
(Direct)
View
2024-02-26
Exercise
2024-02-28
5:14 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,000$1.121,537,137
(Direct)
View
2024-02-26
Exercise
2024-02-28
5:14 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,000$01,537,137
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:35 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNPhillips Andrew John
Director
23,364$023,364
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:32 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
29,205$029,205
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:30 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
23,364$023,364
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:27 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNDerynck Mika K
Director
23,364$023,364
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:26 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNBauer Jake
Director
23,364$023,364
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:24 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
23,364$023,364
(Direct)
View
2024-02-13
Option Award
2024-02-15
9:04 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNPhillips Andrew John
Director
16,835$016,835
(Direct)
View
2024-02-13
Option Award
2024-02-15
9:02 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
185,000$0185,000
(Direct)
View
2024-02-13
Option Award
2024-02-15
9:00 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
185,000$0185,000
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:56 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
410,000$0410,000
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:54 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
185,000$0185,000
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:52 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
21,043$021,043
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:50 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
16,835$016,835
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:48 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNDerynck Mika K
Director
16,835$016,835
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:46 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNCollins Helen Louise
CHIEF MEDICAL OFFICER
185,000$0185,000
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:44 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNBauer Jake
Director
16,835$016,835
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:41 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
16,835$016,835
(Direct)
View
2024-01-29
Exercise
2024-01-31
9:22 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,000$1.121,401,585
(Direct)
View
2024-01-29
Exercise
2024-01-31
9:22 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,000$01,401,585
(Direct)
View
2024-01-29
Exercise
2024-01-31
9:20 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0245,870
(Direct)
View
2024-01-29
Exercise
2024-01-31
9:20 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48245,870
(Direct)
View
2024-01-25
Exercise
2024-01-29
8:01 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
12,000$1.121,549,137
(Direct)
View
2024-01-25
Exercise
2024-01-29
8:01 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
12,000$01,549,137
(Direct)
View
2023-12-29
Exercise
2024-01-03
7:01 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
12,000$1.121,413,585
(Direct)
View
2023-12-29
Exercise
2024-01-03
7:01 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
12,000$01,413,585
(Direct)
View
2023-12-28
Exercise
2024-01-02
7:59 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
11,870$0766,146
(Direct)
View
2023-12-28
Exercise
2024-01-02
7:59 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
11,870$2.48766,146
(Direct)
View
2023-12-26
Exercise
2023-12-28
4:29 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
12,000$1.121,561,137
(Direct)
View
2023-12-26
Exercise
2023-12-28
4:29 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
12,000$01,561,137
(Direct)
View
2023-12-22
Exercise
2023-12-27
5:26 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
1,130$0522,080
(Direct)
View
2023-12-22
Exercise
2023-12-27
5:26 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
1,130$2.48522,080
(Direct)
View
2023-12-21
Exercise
2023-12-26
7:32 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
6,566$1.121,740,681
(Direct)
View
2023-12-21
Exercise
2023-12-26
7:32 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
6,566$01,740,681
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next